Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GSK's First Biologic Treatment For Asthma - Nucala Holds Multi-Billion Dollar Potential
GSK's First Biologic Treatment For Asthma - Nucala Holds Multi-Billion Dollar Potential
GSK's First Biologic Treatment For Asthma - Nucala Holds Multi-Billion Dollar Potential
Submitted by
admin
on February 3, 2016 - 9:01pm
Source:
Seeking Alpha
News Tags:
GSK
biologics
asthma
Nucala
Headline:
GSK's First Biologic Treatment For Asthma - Nucala Holds Multi-Billion Dollar Potential
Do Not Allow Advertisers to Use My Personal information
